Prothena Corporation plc Reports Second Quarter 2013 Financial Results
8/13/2013 9:41:34 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
DUBLIN, Ireland, Aug. 12, 2013 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a clinical stage biotechnology company focused on the discovery and development of novel antibodies for the potential treatment of a broad range of diseases, today reported financial results for the second quarter and six months ended June 30, 2013 and provided an update on research and development.
Help employers find you! Check out all the jobs and post your resume.